Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title |
Type |
$ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| A Prospective, Randomized, Open-Label, Comparative Study to Assess the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) and Best Available Therapy for the Treatment of Serious... | Contract | $240,575.50 | Clinical Trial | Bellal Joseph | Surgery | Parexel International Corporation | 03/2020 |
| Expanded Access Program Basis for the Treatment of Relapsed/Refractory Multiple Myeloma | Contract | $95,540.64 | Clinical Trial | Krisstina Gowin | Cancer Center Division | Glaxosmithkline | 06/2020 |
| Infectious Disease Hotline | Contract | $786,504.00 | Other Sponsored Activity | Steven Dudley | COM Phx Ctr Tox&Pharm Ed&Res | Arizona Department of Health Services | 08/2020 |
| A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase | Contract | $664,687.53 | Clinical Trial | Hani Babiker | Cancer Center Division | PPD Investigator Services, LLC. | 05/2020 |
| A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS) | Contract | $167,627.92 | Clinical Trial | Christian Bime | Medicine | Kinevant Sciences, Inc. | 10/2020 |
| A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects with Mild to Moderate Coronavirus Disease... | Contract | $502,490.72 | Clinical Trial | Thomas Ardiles | COM Phx Internal Medicine | Pharmaceutical Research Associates | 07/2020 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open Label... | Contract | $107,762.52 | Clinical Trial | David Labiner | Neurology | NCGS Incorporated | 03/2020 |
| Student Aid for Field Epidemiology Response (SAFER) - Pinal County Intergovernmental Agreement (IGA) | Contract | $299,814.00 | Instruction | Kristen Pogreba Brown | Epidemiology and Biostatistics | Pinal County, Arizona | 09/2020 |
| PRECISE: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization | Contract | $54,987.52 | Clinical Trial | Michael Morris | COM Phx Radiology | HeartFlow, Inc. | 06/2020 |
| A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately | Contract | $395,132.40 | Clinical Trial | Sasha Taleban | Medicine | PPD Investigator Services, LLC. | 05/2020 |
| A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Recept | Contract | $854,975.00 | Clinical Trial | Hani Babiker | Cancer Center Division | AbbVie Incorporated | 10/2020 |
| A Three-Arm Study of ME-401 Monotherapy in Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Follicular Lymphoma (FL), of ME-401 in Combination... | Contract | $298,700.00 | Clinical Trial | Daniel Persky | Cancer Center Division | Clinipace Worldwide | 07/2020 |
| ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects InDicatEd for TAVR | Contract | $115,544.00 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | Boston Scientific Corporation | 03/2020 |
| Behavior Change Smoking Cessation - Arizona Department of Administration | Contract | $45,000.00 | Other Sponsored Activity | Mark Martz | Public Hlth Pract & Trans Rsch | Arizona Department of Administration | 09/2020 |
| Total Shoulder Arthroplasty Multi-Center Registry | Contract | $603,643.00 | Clinical Trial | Joshua Hustedt | COM Phx Orthopedics | Arthrex, Incorporated | 06/2020 |
| Rapid Diagnosis of Coccidioidomycosis Assay Comparison | Contract | $114,999.00 | Research | Fariba Donovan | Valley Fever Ctr for Excellnc | Centers for Disease Control and Prevention | 11/2020 |
| Arizona Statewide Alzheimer's Research | Contract | $22,500.00 | Research | Jonathan Lifshitz | COM Phx Child Health | Arizona Alzheimer's Consortium | 09/2020 |
| Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w | Contract | $17,187.52 | Clinical Trial | Kresimira Milas | Surgery | Bard Peripheral Vascular, Inc. | 05/2020 |
| A Phase 2 Randomized Study of Adjuvant Immunotherapy with the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma | Contract | $206,150.52 | Clinical Trial | Montaser Shaheen | Cancer Center Division | PPD Investigator Services, LLC. | 10/2020 |
| Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-Type, Left-Sided Colorectal Cancer | Contract | $127,173.74 | Clinical Trial | Aaron Scott | Cancer Center Division | Academic Gastrointestinal Cancer Consortium | 03/2020 |
| Zephyr Valve Registry (ZEVR) | Contract | $148,825.60 | Clinical Trial | Raed Alalawi | COM Phx Internal Medicine | Pulmonx Corporation | 06/2020 |
| A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma | Contract | $258,643.47 | Clinical Trial | Jared Robbins | Cancer Center Division | Regeneron Pharmaceuticals, Inc | 02/2020 |
| Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) | Contract | $159,936.00 | Clinical Trial | Pavani Chalasani | Cancer Center Division | IQVIA RDS Inc. | 02/2020 |
| Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer | Contract | $323,394.75 | Clinical Trial | Hani Babiker | Cancer Center Division | Vedanta Biosciences, Inc. | 05/2020 |
| Neutralizing Nanobodies as Therapeutics for Dengue Virus | Contract | $196,211.00 | Research | Hongmin Li | Pharmacology and Toxicology | Health Research, Incorporated | 01/2021 |